FOX
70
-3
ADT
32
4
NRG
37
-2
D
37
2
AAP
32
2
F
42
2
GILD
58
2
TROW
50
2
FAST
42
-2
EQT
45
-3
PHM
50
2
HCP
54
-2
ZTS
43
3
K
56
3
EOG
30
-2
PLD
45
5
IFF
45
-2
ORLY
48
-4
BAX
41
2
SE
58
-2
FOX
70
-3
ADT
32
4
NRG
37
-2
D
37
2
AAP
32
2
F
42
2
GILD
58
2
TROW
50
2
FAST
42
-2
EQT
45
-3
PHM
50
2
HCP
54
-2
ZTS
43
3
K
56
3
EOG
30
-2
PLD
45
5
IFF
45
-2
ORLY
48
-4
BAX
41
2
SE
58
-2
Financhill
Back

Biomarin Pharmaceutical Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Buy
64

BMRN
Biomarin Pharmaceutical

Last Price:
$67.02
Seasonality Move:
5.39%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Biomarin Pharmaceutical Stock Forecast

  • Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.8% based on the past 25 years of stock performance.
  • Biomarin Pharmaceutical has risen higher in 13 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 52%
  • Is Biomarin Pharmaceutical Stock Undervalued?
    The current Biomarin Pharmaceutical [BMRN] share price is $67.02. The Score for BMRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Biomarin Pharmaceutical Stock Go Up Next Year?

  • Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.8% based on the past 25 years of stock performance.

Biomarin Pharmaceutical Stock Rating

Buy
64
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical overpriced?

  • Biomarin Pharmaceutical has risen higher in 13 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 52%

Biomarin Pharmaceutical Stock Price History

Is BMRN stock going to rise?

  • The current trend is relatively stagnant and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com

52-Week Data

52-Week High:
99.25
52-Week Low:
61.15

Prediction Charts

Market Cap:
12.8B
Price in USD:
67.02
Volume:
910.1K
Beta:
0.87

Technical Analysis

SMA50:
66.48
SMA100:
73.57
SMA200:
78.63
52-Wk Change:
-30.52%

Stock Predictions

  • Is Biomarin Pharmaceutical stock public?
    Yes, Biomarin Pharmaceutical is a publicly traded company.
  • What is the Biomarin Pharmaceutical stock quote today?
    The Biomarin Pharmaceutical stock price is 67.02 USD today.
  • How to buy Biomarin Pharmaceutical stock online?
    You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-6 66.89 66.74 67.20 65.79
Dec-9 66.33 66.81 67.87 66.33
Dec-10 67.00 66.43 67.07 66.13
Dec-11 66.42 65.97 67.05 65.49
Dec-12 65.45 66.26 66.68 65.35
Dec-13 66.08 66.01 66.27 64.89
Dec-16 66.50 65.54 67.17 65.42
Dec-17 64.89 67.19 67.85 64.80
Dec-18 67.19 64.66 67.58 64.60
Dec-19 64.63 65.00 65.62 63.93
Dec-20 64.90 65.69 66.27 64.07
Dec-23 65.07 66.27 66.46 64.65
Dec-24 65.96 66.63 67.09 65.25
Dec-26 66.30 67.02 67.10 66.21

Biomarin Pharmaceutical Earnings

Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.

Biomarin Pharmaceutical Forecast Revenue Growth

Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.

* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.